Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v4-FR
Language English French
Date Updated 2020-04-24 2020-04-23
Drug Identification Number 02341689 02341689
Brand name GD-DICLOFENAC/MISOPROSTOL 50 GD-DICLOFENAC/MISOPROSTOL 50
Common or Proper name GD-DICLO/MISO 50 GD-DICLO/MISO 50
Company Name GENMED A DIVISION OF PFIZER CANADA ULC GENMED A DIVISION OF PFIZER CANADA ULC
Ingredients MISOPROSTOL DICLOFENAC SODIUM MISOPROSTOL DICLOFENAC SODIUM
Strength(s) 200MCG 50MG 200MCG 50MG
Dosage form(s) TABLET (DELAYED-RELEASE) TABLET (DELAYED-RELEASE)
Route of administration ORAL ORAL
Packaging size 250's 250's
ATC code M01AB M01AB
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2020-03-19 2020-03-19
Estimated end date 2020-12-30 2020-12-30
Actual end date 2020-04-23 2020-04-23
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Current available inventory and scheduled deliveries will be preventatively managed through local allocation until approximately end of December 2020. Other presentation available: Arthrotec 50mg Current available inventory and scheduled deliveries will be preventatively managed through local allocation until approximately end of December 2020. Other presentation available: Arthrotec 50mg
Health Canada comments